Medlab Clinical Ltd. is a biotechnology company, which engages in the development of nutraceutical products for chronic diseases and mental health conditions. It operates through the Nutraceutical and Pharmaceutical Research segments. The Pharmaceutical Research segment focuses on depression and oncology, and the supply of cannabis-based medicines. The company was founded by Sean Hall on June, 2012 and is headquartered in Perth, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Medlab Clinical Limited?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Medlab Clinical Limited market cap is $15.98M.
What is the 52-week high for Medlab Clinical Limited?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medlab Clinical Limited 52 week high is $7.00 as of September 06, 2025.
What is the 52-week low for Medlab Clinical Limited?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medlab Clinical Limited 52 week low is $7.00 as of September 06, 2025.
What is Medlab Clinical Limited stock price today?
Medlab Clinical Limited stock price today is $7.00.
What was Medlab Clinical Limited stock price yesterday?
Medlab Clinical Limited stock price yesterday was $7.00.
What is the PE ratio of Medlab Clinical Limited?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Medlab Clinical Limited’s P/E ratio is -6.11.
What is the Price-to-Book ratio of Medlab Clinical Limited?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Medlab Clinical Limited P/B ratio is -33.4400.
What is the 50-day moving average of Medlab Clinical Limited?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Medlab Clinical Limited 50-day moving average is $7.00.
